Dapagliflozin DPPIV Inhibitor add-on Study

Clinical trial NCT00984867 · COMPLETED

Trial details

NCT number: NCT00984867
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2009-10-01
Primary completion: 2011-03-01
Enrollment: 833

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.